SKK
KIN

Shepherd Kaplan Krochuk’s Kindred Biosciences, Inc. KIN Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-24,116
Closed -$170K – 281
2017
Q1 		$170K Sell
24,116
-22,800
-49% -$143K 0.09% 171
2016
Q4 		$199K Sell
46,916
-47,884
-51% -$232K 0.06% 173
2016
Q3 		$473K Buy
94,800
+32,500
+52% +$137K 0.1% 145
2016
Q2 		$221K Buy
+62,300
New +$229K 0.05% 231

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Shepherd Kaplan Krochuk's KIN Position: Q2 2017 in Review

Shepherd Kaplan Krochuk sold out of Kindred Biosciences, Inc. (KIN) in Q2 2017, closing a stake of 24,116 shares — an estimated $170K sold.

Shepherd Kaplan Krochuk first reported a position in KIN in Q2 2016 and held it in 4 quarters. The position peaked at $473K in Q3 2016. 66 funds tracked by Wall St. Rank hold KIN as of Q2 2017.

  • Shepherd Kaplan Krochuk reported no remaining Kindred Biosciences, Inc. position as of Q2 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 24,116 Kindred Biosciences, Inc. shares in Q2 2017, an estimated $170K.
  • Shepherd Kaplan Krochuk first reported a position in Kindred Biosciences, Inc. in Q2 2016 and held it in 4 quarters.
  • Shepherd Kaplan Krochuk's Kindred Biosciences, Inc. position peaked at $473K in Q3 2016.
  • 66 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q2 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2017, filed 10 Aug 2017.